TELBIVUDINE for Hiv infection: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 20 adverse event reports in the FDA FAERS database where TELBIVUDINE was used for Hiv infection.
Most Reported Side Effects for TELBIVUDINE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Drug resistance | 103 | 23.7% | 0 | 10 |
| Blood creatine phosphokinase increased | 84 | 19.4% | 2 | 43 |
| Foetal exposure during pregnancy | 58 | 13.4% | 13 | 3 |
| Myalgia | 49 | 11.3% | 2 | 22 |
| Drug ineffective | 37 | 8.5% | 0 | 6 |
| Pathogen resistance | 37 | 8.5% | 0 | 6 |
| Muscular weakness | 33 | 7.6% | 1 | 19 |
| Maternal exposure during pregnancy | 31 | 7.1% | 0 | 3 |
| Treatment failure | 31 | 7.1% | 0 | 0 |
| Asthenia | 26 | 6.0% | 3 | 18 |
| Viral mutation identified | 25 | 5.8% | 0 | 0 |
| Rhabdomyolysis | 24 | 5.5% | 3 | 12 |
| Hepatic cirrhosis | 20 | 4.6% | 5 | 16 |
| Myopathy | 20 | 4.6% | 0 | 12 |
| Vomiting | 20 | 4.6% | 5 | 14 |
Other Indications for TELBIVUDINE
Chronic hepatitis b (153)
Hepatitis b (111)
Product used for unknown indication (52)
Foetal exposure during pregnancy (30)
Hepatic cirrhosis (12)
Antiviral treatment (11)
Viral infection (9)
Hepatitis viral (8)
Other Drugs Used for Hiv infection
EMTRICITABINE\TENOFOVIR DISOPROXIL (27,672)
TENOFOVIR DISOPROXIL (19,662)
EFAVIRENZ\EMTRICITABINE\TENOFOVIR DISOPROXIL (15,794)
LAMIVUDINE (8,963)
DOLUTEGRAVIR (7,207)
COBICISTAT\ELVITEGRAVIR\EMTRICITABINE\TENOFOVIR DISOPROXIL (6,874)
RITONAVIR (6,739)
EMTRICITABINE\RILPIVIRINE\TENOFOVIR DISOPROXIL (5,840)
EFAVIRENZ (5,261)
BICTEGRAVIR\EMTRICITABINE\TENOFOVIR ALAFENAMIDE (4,854)